Welsh, Paul
Rankin, Naomi
Li, Qiang
Mark, Patrick B.
Würtz, Peter
Ala-Korpela, Mika
Marre, Michel
Poulter, Neil
Hamet, Pavel
Chalmers, John
Woodward, Mark
Sattar, Naveed
Funding for this research was provided by:
Suomen Akatemia (312476 and 312477)
National Health and Medical Research Council (Project grant ID 211086 and program grants IDs 358)
Chest Heart and Stroke Scotland (R13/A149)
Medical Research Council (MR/N005813/1)
Article History
Received: 5 January 2018
Accepted: 21 March 2018
First Online: 4 May 2018
Duality of interest
: JC has received Research grants from Servier as Principal investigator for ADVANCE and for the ADVANCE-ON post trial follow-up study and honoraria from Servier for speaking about these studies at scientific meetings. MW reports receiving consulting fees from Amgen. PWu is an employee and shareholder of Nightingale Health Ltd, which conducted the biomarker quantification. All other authors declare that there is no duality of interest associated with their contribution to this paper.